Independent Research set a €54.00 ($64.29) target price on Carl Zeiss Meditec (ETR:AFX) in a research note issued to investors on Friday, December 8th. The firm currently has a neutral rating on the stock.
Other equities analysts also recently issued reports about the stock. Berenberg Bank set a €48.00 ($57.14) price target on shares of Carl Zeiss Meditec and gave the stock a buy rating in a research note on Tuesday, October 17th. DZ Bank reiterated a sell rating on shares of Carl Zeiss Meditec in a research report on Thursday, October 19th. Deutsche Bank set a €40.00 ($47.62) target price on Carl Zeiss Meditec and gave the stock a neutral rating in a report on Friday, December 1st. Commerzbank set a €42.00 ($50.00) target price on Carl Zeiss Meditec and gave the stock a neutral rating in a report on Friday, December 8th. Finally, set a €52.00 ($61.90) target price on Carl Zeiss Meditec and gave the stock a buy rating in a report on Friday, November 10th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and four have given a buy rating to the stock. The stock has a consensus rating of Hold and an average price target of €50.36 ($59.95).
Carl Zeiss Meditec (ETR AFX) traded down €0.36 ($0.43) during midday trading on Friday, reaching €51.40 ($61.19). 54,435 shares of the company’s stock were exchanged, compared to its average volume of 91,142. Carl Zeiss Meditec has a 1-year low of €33.62 ($40.02) and a 1-year high of €53.35 ($63.51). The stock has a market cap of $4,630.00 and a P/E ratio of 32.74.
Carl Zeiss Meditec Company Profile
Carl Zeiss Meditec AG operates as a medical technology company worldwide. It operates through Ophthalmic Devices and Microsurgery segments. The Ophthalmic Devices segment offers optical biometers, ophthalmic microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.